Compare $NPCE vs $OBIO | Chartloom

Compare

$NPCE vs $OBIO

Neuropace Inc · Orchestra Biomed Holdings Inc

NPCE

Neuropace Inc

OBIO

Orchestra Biomed Holdings Inc

Compare $NPCE vs $OBIO

Comparing Neuropace Inc and Orchestra Biomed Holdings Inc

NPCENeuropace Inc

OBIOOrchestra Biomed Holdings Inc

NPCENeuropace Inc

Market cap

$432M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

11.6%

YTD performance

-16.5%

52W performance

13.8%

FCF yield

-2.7%

OBIOOrchestra Biomed Holdings Inc

Market cap

$356M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

789.20x

Rev growth (TTM)

986.1%

YTD performance

38.1%

52W performance

105.2%

FCF yield

-16.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NPCE

OBIO

Detailed metrics comparison

NPCE

Neuropace Inc

OBIO

Orchestra Biomed Holdings Inc

Market Cap

NPCE$432M

OBIO$356M

Enterprise Value

NPCE$478M

OBIO$371M

Price

NPCE$12.67

OBIO$5.95

P/E Ratio

NPCEN/A

OBION/A

P/S Ratio

NPCE4.37x

OBIO11.14x

EV/Sales

NPCE4.84x

OBIO11.59x

EV/EBITDA

NPCE0.00x

OBIO0.00x

P/B Ratio

NPCE36.68x

OBIO12.16x

P/FCF Ratio

NPCEN/A

OBION/A

EV/FCF

NPCE-41.21x

OBIO-6.27x

PEG Ratio

NPCEN/A

OBION/A

Forward P/E (NTM)

NPCEN/A

OBION/A

Forward P/S (NTM)

NPCE3.83x

OBIO789.20x

Revenue (TTM)

NPCE$99M

OBIO$32M

Revenue Growth (YoY)

NPCE11.6%

OBIO986.1%

Forward Rev Growth

NPCE22.0%

OBIO51.2%

Gross Margin (TTM)

NPCE79.6%

OBIO99.5%

Operating Margin (TTM)

NPCE0.0%

OBIO0.0%

EBITDA Margin (TTM)

NPCE-15.0%

OBIO-180.3%

Net Margin (TTM)

NPCE-19.3%

OBIO-186.3%

FCF Margin (TTM)

NPCE-11.7%

OBIO-184.8%

Net Income (TTM)

NPCE$-19M

OBIO$-60M

FCF (TTM)

NPCE$-12M

OBIO$-59M

EPS (TTM)

NPCE-$0.56

OBIO-$0.93

ROE (TTM)

NPCE-11968.0%

OBIO-12578.0%

ROA (TTM)

NPCE-1871.0%

OBIO-5409.0%

ROIC (TTM)

NPCE-2552.0%

OBIO-8895.0%

Cash

NPCE$13M

OBIO$20M

Debt

NPCE$59M

OBIO$35M

Net Cash/Debt

NPCE$-46M

OBIO$-14M

Current Ratio (TTM)

NPCE4.94x

OBIO8.26x

Quick Ratio (TTM)

NPCE3.82x

OBIO8.17x

Debt/Equity (TTM)

NPCE4.97x

OBIO1.18x

Debt/Assets (TTM)

NPCE0.0%

OBIO0.0%

Interest Coverage (TTM)

NPCEN/A

OBION/A

Net Debt/EBITDA (TTM)

NPCE0.00x

OBIO0.00x

Beta

NPCE1.95

OBIO0.55

52W Performance

NPCE13.8%

OBIO105.2%

YTD Performance

NPCE-16.5%

OBIO38.1%

% from 52W High

NPCE-35.4%

OBIO-8.5%

% from 52W Low

NPCE37.4%

OBIO114.1%

Asset Turnover (TTM)

NPCE0.97x

OBIO0.29x

FCF Yield (TTM)

NPCE-2.7%

OBIO-16.6%

Earnings Yield (TTM)

NPCE-4.4%

OBIO-16.7%

Dividend Yield (TTM)

NPCEN/A

OBION/A

Rule of 40

NPCE-0.2

OBIO801.3

EV/GP/RG

NPCE0.40

OBIO0.17

Ticker research

View NPCE research View OBIO research

Metric	NPCE Neuropace Inc	OBIO Orchestra Biomed Holdings Inc
Market & Valuation
Market Cap	$432M	$356M
Enterprise Value	$478M	$371M
Price	$12.67	$5.95
P/E Ratio	N/A	N/A
P/S Ratio	4.37x	11.14x
EV/Sales	4.84x	11.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	36.68x	12.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.21x	-6.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	789.20x
Revenue & Growth
Revenue (TTM)	$99M	$32M
Revenue Growth (YoY)	11.6%	986.1%
Forward Rev Growth	22.0%	51.2%
Profitability
Gross Margin (TTM)	79.6%	99.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-15.0%	-180.3%
Net Margin (TTM)	-19.3%	-186.3%
FCF Margin (TTM)	-11.7%	-184.8%
Net Income (TTM)	$-19M	$-60M
FCF (TTM)	$-12M	$-59M
EPS (TTM)	-$0.56	-$0.93
ROE (TTM)	-11968.0%	-12578.0%
ROA (TTM)	-1871.0%	-5409.0%
ROIC (TTM)	-2552.0%	-8895.0%
Financial Health
Cash	$13M	$20M
Debt	$59M	$35M
Net Cash/Debt	$-46M	$-14M
Current Ratio (TTM)	4.94x	8.26x
Quick Ratio (TTM)	3.82x	8.17x
Debt/Equity (TTM)	4.97x	1.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.55
52W Performance	13.8%	105.2%
YTD Performance	-16.5%	38.1%
% from 52W High	-35.4%	-8.5%
% from 52W Low	37.4%	114.1%
Efficiency & Yields
Asset Turnover (TTM)	0.97x	0.29x
FCF Yield (TTM)	-2.7%	-16.6%
Earnings Yield (TTM)	-4.4%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.2	801.3
EV/GP/RG	0.40	0.17
Ticker research	View NPCE research	View OBIO research

Valuation

P/S Ratio

NPCE

4.37x

OBIO

11.14x

EV/FCF

NPCE

-41.21x

OBIO

-6.27x

Growth & revenue

Revenue Growth TTM

OBIO

986.1%

NPCE

11.6%

Forward Revenue Growth

OBIO

51.2%

NPCE

22.0%

Profitability & performance

Gross Margin

OBIO

99.5%

NPCE

79.6%

ROE

NPCE

-11968.0%

OBIO

-12578.0%

FCF Yield %

NPCE

-2.7%

OBIO

-16.6%

52-Week Performance

OBIO

105.2%

NPCE

13.8%

Detailed metrics comparison

NPCE

Neuropace Inc

OBIO

Orchestra Biomed Holdings Inc

Market Cap

NPCE$432M

OBIO$356M

Enterprise Value

NPCE$478M

OBIO$371M

Price

NPCE$12.67

OBIO$5.95

P/E Ratio

NPCEN/A

OBION/A

P/S Ratio

NPCE4.37x

OBIO11.14x

EV/Sales

NPCE4.84x

OBIO11.59x

EV/EBITDA

NPCE0.00x

OBIO0.00x

P/B Ratio

NPCE36.68x

OBIO12.16x

P/FCF Ratio

NPCEN/A

OBION/A

EV/FCF

NPCE-41.21x

OBIO-6.27x

PEG Ratio

NPCEN/A

OBION/A

Forward P/E (NTM)

NPCEN/A

OBION/A

Forward P/S (NTM)

NPCE3.83x

OBIO789.20x

Revenue (TTM)

NPCE$99M

OBIO$32M

Revenue Growth (YoY)

NPCE11.6%

OBIO986.1%

Forward Rev Growth

NPCE22.0%

OBIO51.2%

Gross Margin (TTM)

NPCE79.6%

OBIO99.5%

Operating Margin (TTM)

NPCE0.0%

OBIO0.0%

EBITDA Margin (TTM)

NPCE-15.0%

OBIO-180.3%

Net Margin (TTM)

NPCE-19.3%

OBIO-186.3%

FCF Margin (TTM)

NPCE-11.7%

OBIO-184.8%

Net Income (TTM)

NPCE$-19M

OBIO$-60M

FCF (TTM)

NPCE$-12M

OBIO$-59M

EPS (TTM)

NPCE-$0.56

OBIO-$0.93

ROE (TTM)

NPCE-11968.0%

OBIO-12578.0%

ROA (TTM)

NPCE-1871.0%

OBIO-5409.0%

ROIC (TTM)

NPCE-2552.0%

OBIO-8895.0%

Cash

NPCE$13M

OBIO$20M

Debt

NPCE$59M

OBIO$35M

Net Cash/Debt

NPCE$-46M

OBIO$-14M

Current Ratio (TTM)

NPCE4.94x

OBIO8.26x

Quick Ratio (TTM)

NPCE3.82x

OBIO8.17x

Debt/Equity (TTM)

NPCE4.97x

OBIO1.18x

Debt/Assets (TTM)

NPCE0.0%

OBIO0.0%

Interest Coverage (TTM)

NPCEN/A

OBION/A

Net Debt/EBITDA (TTM)

NPCE0.00x

OBIO0.00x

Beta

NPCE1.95

OBIO0.55

52W Performance

NPCE13.8%

OBIO105.2%

YTD Performance

NPCE-16.5%

OBIO38.1%

% from 52W High

NPCE-35.4%

OBIO-8.5%

% from 52W Low

NPCE37.4%

OBIO114.1%

Asset Turnover (TTM)

NPCE0.97x

OBIO0.29x

FCF Yield (TTM)

NPCE-2.7%

OBIO-16.6%

Earnings Yield (TTM)

NPCE-4.4%

OBIO-16.7%

Dividend Yield (TTM)

NPCEN/A

OBION/A

Rule of 40

NPCE-0.2

OBIO801.3

EV/GP/RG

NPCE0.40

OBIO0.17

Ticker research

View NPCE research View OBIO research

Metric	NPCE Neuropace Inc	OBIO Orchestra Biomed Holdings Inc
Market & Valuation
Market Cap	$432M	$356M
Enterprise Value	$478M	$371M
Price	$12.67	$5.95
P/E Ratio	N/A	N/A
P/S Ratio	4.37x	11.14x
EV/Sales	4.84x	11.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	36.68x	12.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.21x	-6.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	789.20x
Revenue & Growth
Revenue (TTM)	$99M	$32M
Revenue Growth (YoY)	11.6%	986.1%
Forward Rev Growth	22.0%	51.2%
Profitability
Gross Margin (TTM)	79.6%	99.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-15.0%	-180.3%
Net Margin (TTM)	-19.3%	-186.3%
FCF Margin (TTM)	-11.7%	-184.8%
Net Income (TTM)	$-19M	$-60M
FCF (TTM)	$-12M	$-59M
EPS (TTM)	-$0.56	-$0.93
ROE (TTM)	-11968.0%	-12578.0%
ROA (TTM)	-1871.0%	-5409.0%
ROIC (TTM)	-2552.0%	-8895.0%
Financial Health
Cash	$13M	$20M
Debt	$59M	$35M
Net Cash/Debt	$-46M	$-14M
Current Ratio (TTM)	4.94x	8.26x
Quick Ratio (TTM)	3.82x	8.17x
Debt/Equity (TTM)	4.97x	1.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.55
52W Performance	13.8%	105.2%
YTD Performance	-16.5%	38.1%
% from 52W High	-35.4%	-8.5%
% from 52W Low	37.4%	114.1%
Efficiency & Yields
Asset Turnover (TTM)	0.97x	0.29x
FCF Yield (TTM)	-2.7%	-16.6%
Earnings Yield (TTM)	-4.4%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.2	801.3
EV/GP/RG	0.40	0.17
Ticker research	View NPCE research	View OBIO research